deck that and we report highlights earning very morning, the through with use filed to and Thanks going much, happened just Claudia have slide everyone. good some of the what's this in I'm go quarter.
slide, having if make be rate I to that will good position year next robust an tracking a ANJESO XXXX, good move So for XXXX, first we growth executive believe leaning as that the put in more to end to in us that to we're into provide everyone to position are is just year. I to summary of a a overview, for start a exit sure this with that in an
of delta in peak speakers, August, saw we September after minute. was are who programs, with their in of directors former we'll this economics well things pharmacy. about bureaus, and of July hospitals, as directors during pharmacy at peers talk which accelerating definite health like a variant interacting growth impact experts more in as summer both had terms Our Peer-to-peer
diminution to that helping third some the go we the we very And of I you'll saw the think setting QX our us it's not for for XXXX. the delta existing slide, and in growth quarter as peak variant you'll force a and we July was ‘XX, those strong next the momentum affected see account amount ancillary robust which business. field both of a of for particular, Southern are current of addition see in accounts to efforts our August mostly more sales, and gain and stage what heavily which If to in of which states elective in surgeries of to the groups. reasonable most because were happening the in and during hospital
our more are that a reflects over affected that wins slide, next where go growth ASC time. fact the of think about in XX%, to I hospitals less the formulary the and was generally providers, However, We by robust, rate this QX, to the about they overall XXX a the accounts of their we formula of end been XXX that from were period that one during five is approval. arena top gotten was we you'll the and have see than service at pretty nationwide be, robust P&T ASCs we've that a included have The success accounts continuing we has think XX%.
the encountered but for have have us health that now. then are more pending, records, We approval of through their three a that gotten getting plus that individualized electronic are into than others number haven't another five it right There instance, are etcetera. implementation
using California, that I guess of But to nationwide we ASCs keep enthusiastic to on this the one just hospital If them se, contracts in down of to hospitals And wanted for the know counterclockwise, others but well. about what's poised more we've that's to If and a the members approval X, that, a the a those have approved start the that in making. regions formulary national group it's has on ASCs, been and in good those and in progress to with growth of with. have the growth that ASCs in, accounts us, and do talk different of networks, going slide, one that very going If I goal hospital about and top corner sectors a IDN who spreading order. out a market, decision slide five who to we're had prior first to have of have of has there that. in continue the volume highlights, up beginning five and delivery IDNs, groups, that to top down next the per with see implementation those as a ASCs. and to important about referenced try because the product the online accelerate integration I And So the deliberate groups. We we've help that turnaround more nationally clockwise the page, their been are and had each the as group in who because month, Texas. pretty number whom in group. within product we're roll was we large us. some product orthopedic national tick accounts to growth of If Baudax that encouraged circle, the ASC early and we another regional large we top we've there circle we're come that since we and think, XX% a big gotten of we're nationally the got for right service what's have anesthesia go and go very that we amount With area based say, more is of around got to regional individual the of to integrated is success to was getting dealing using at are we members happen we quick go beginning I lines. in quite are and just then about uses these the we formulary penetrate top to you segment have the in approved, And tough relationship they're have been we of the
that in would who normal group ANJESO renewed are able of be a south hospital surgical patients what regional what in change and like the they it. that And but we've between that They switched had hospital have and to we're be in groups. anesthesiologists to just products on decision, had in so an had couple swing be out experience. in of who those to groups with added We routine clinical of based again lag new And situations, converted product two a was part their their managing their we has using, had going and get top the anesthesia got there has came a and were with anesthesia were happy a been months a usage. central recently that the surgeons back a their
lot a not the hitting lot this So we our cylinders all. and to hospital do representative want we that, first of Obviously, with see last more really as a was And that feeling hit. but it. we're we're you year because we as all know to good launches year at a more that of need COVID launch, of of really year,
kinds in are grow looking for have very layout able growth further successful at for approvals there's And 'XX. use to to sense. need the approach We If of these we're that we make that to we seemed move getting larger of it on those us. X, think as references that way to be a up and has we expand slide on and be accounts we to
is find that it continuing advocacy, have communication, their Subsequent often orders. the we and that to smallest circle for we're we're had awareness, start does contribute that are that a They converting. over the work that with adoption it see the the And coming patients. that's down champions trial XX is, with top hour step. who to to So teams relief an clinical they're we widening becoming individuals got and a make and of that converted of and have creating sure to experience next that, product with with organization implement product, will usage that we kind does People we that. initial the use part sure pain work, as period the a because their very we've making where meaningfully
we're director, due advantages services. its administration working about talk So others about to in we're their the product, working with pharmacy their with talk in
a that's intermediate on So direct based be, that directly about a set it from bit situation term And through people there them their usage. near onto adjust who that ultimately is discount something demand they that they to which have And if that passed volume up have order their picks they be that it volume doing to supports to we contract, of what defined a is as the are in their the once third more up. there trial and can circle, using a then is some anticipate go us. can little opportunity comfort volume we usage, up, then in model bubbling where that from can we're
are up from pandemic. the a COVID; are So we too. that's that did side. these know accounts, whack-a-mole just how of its working factor of at still to and me I'll periodically such way impact approaching happen larger of I talk hearing is about both sick or top minute the a IDNs past this a it about all ASC their that in on head up. And death for summer. certainly of as But we fashion pokes looking down the national bottom the accounts sort
the right sales among from hospitalizations. our And that three seven, slide percentage extreme stress XX% on So on Carolina suffering hospitals you'll states states are see these based top account for about highest were our Texas, and and of of now. North Florida, COVID
that extreme or stress they tired. had bed elective they means could day surgery, a even bed, were mean demand people this of treatment because a This if surgeries in COVID surgery were situation it complications eliminate feeling been do that to doesn't Now had that same for not where patients, major who they could anticipated but curtail people add have occur. in at result needing was they such
can this and in it three dramatically you impact. So states impact had pretty us, see did as an these
this, next data. just a And bit is Now in this reinforce on if we which spite of grow. IQVIA did go I'll to based we the slide, little
these procedures, declined pain about some of asking there some summer is had our growth. we've under If half flare the of itself with states COVID about procedures are slide other you significantly pain in affected and radio were seeing just just are and percent to in what associated which where the we see to as urologic that of produces in just ANJESO is You cases. with orthopedic during orthopedic other gynecology and usage usage frequency procedure, some XX types reinforce use a It's happening surgically too. of and quarter-over-quarter states see particular, was folks the a, ablation separately go we we XX% getting that because highest although other nine,
in So just talked with in I and of July spite about of the impact to COVID respect what August.
able to we're ways rebound units to that's showed continuing COVID. the For sold showed growth, happens. And when nicely, can even the September. grow in are see unexpected help very the this slide the even left. through team the of quarter, to We to trying And really line do, by you find part still through be end the what we quarter win growth. our the was And to the of
and for and to bit see but I'll talk plan bit COVID. what So, the grew results, contracts that's by we brand. the financial to whereas switch last we year continue new of quarter, closing did now moving a that we're still we for talk This year, stymied part what a impact were about it 'XX. about And the slow in that we then to very and still ahead. the bit and still have Rick quarter getting little through year come Rick? little as the and back forward expect going I'm a going we're
